February 3, 2020
Cancer genetic testing revealed that Beth Silverstein was at high risk for breast and ovarian cancer. She took charge of her destiny and took preventive steps through surgery, and now celebrates five years as a "previvor" with a fundraiser for UNC Lineberger.
January 30, 2020
A discovery by University of North Carolina Lineberger Comprehensive Cancer Center researchers could allow scientists to fine-tune genetically engineered immune cells to heighten their killing power against tumors or to decrease their activity level in the case of severe side effects. In a study published in Cancer Cell, researchers led by UNC Lineberger’s Gianpietro Dotti, …
January 24, 2020
Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center can illuminate cells from within using an embedded “biological flashlight,” and then use the light to control the cell’s function. In a proof-of-concept study published in the journal ACS Synthetic Biology, researchers describe an advance in “optogenetics,” a field in which scientists use light …
January 16, 2020
Yuliya Pylayeva-Gupta, PhD, and Gaorav Gupta, MD, PhD, use their natural curiosity and drive to tackle cancer through their research at UNC Lineberger.
January 16, 2020
Comparison shopping for airfare, a TV, or a car can be straightforward online. The same cannot be said for checking what hospitals charge for a standard radiation treatment for prostate cancer, according to a report published in JAMA Oncology. Trevor Royce, MD, MPH, MS, of the University of North Carolina Lineberger Comprehensive Cancer Center, is …
January 14, 2020
The Conquer Cancer Foundation of the American Society of Clinical Oncology, in conjunction with the Breast Cancer Research Foundation, has presented a Young Investigator Award to UNC Lineberger’s Emily Ray, MD, MPH. Ray, who is an assistant professor of medicine in the division of hematology/oncology at UNC School of Medicine, will use the one year, …
January 14, 2020
UNC Lineberger’s Christopher Dittus, DO, MPH, assistant professor of medicine at UNC School of Medicine, is the editor of a new book that provides a comprehensive review of how to diagnose and manage rare lymphomas, with a focus on novel treatment approaches. UNC Lineberger faculty and trainees contributed chapters to the volume. “Novel Therapeutics for …
January 14, 2020
An early-stage clinical study investigating a method of boosting the body’s defenses against two blood cancers found the drug pomalidomide could be safely added to conventional treatments, and help improve immune function. University of North Carolina Lineberger Comprehensive Cancer Center researcher Joshua Zeidner, MD, assistant professor in the UNC School of Medicine Division of Hematology/Oncology, …
January 13, 2020
A study led by UNC Lineberger's Tim Gershon, MD, PhD, shows new evidence to explain how drug resistance develops in a major subtype of medulloblastoma.
January 10, 2020
UNC Lineberger’s Channing Der, PhD, Sarah Graham Kenan Distinguished Professor in the UNC School of Medicine Department of Pharmacology, was co-corresponding author of a paper published in Cancer Discovery. Antje Schaefer, PhD, research assistant professor in the UNC School of Medicine Department of Pharmacology, was co-first author. In the study, researchers identified a new potential …
